This document outlines details of PBS-subsidised tocilizumab for patients with active Giant cell arteritis (GCA).
For information on how to process a PBS Authority, see Processing Complex Authority Required Listings. Contact a Local Peer Support (LPS) if unsure of how to action an application.
Giant cell arteritis (GCA) quick reference
|
Restrictions |
Authority level and section |
PA assessment |
Processing system |
Prescriber type
|
Prescriber self-serve |
|
Initial
PB272 form
Patients aged 50 years or older |
Written
Electronic
S85:
tocilizumab
|
No |
OPA
|
Must be treated by a:
-
rheumatologist
-
clinical immunologist
-
neurologist experienced in the management of GCA
|
Yes |
|
Continuing
|
Telephone
Electronic
S85:
tocilizumab
|
No |
OPA
|
Must be treated by a:
-
rheumatologist
-
clinical immunologist
-
neurologist experienced in the management of GCA
|
Yes |
Expand all